Delivery Order SPE2DR25D3012-SPE2DR26F4C5J
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,320.12 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and pharmaceutical distribution operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,668.19 to AmerisourceBergen Drug Corp for Yupelri 175 micrograms per 3 milliliters solution in unit dose vials. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,310.25 for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,309.59 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials on September 25, 2025, with completion expected by September 26, 2025. This competitive award utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical supplies...
- The Defense Logistics Agency awarded a delivery order valued at $3,226.87 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,916.52 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit-dose vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) calls for the pharmaceutical distributor to deliver the medication to its Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,973.31 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,309.90 on September 12, 2025, for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials, with a ceiling value of $8,823.72. This non-competitive delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed price pricing and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $1,670.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL Solution in unit dose vials. The order, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a pharmaceutical supply delivery supporting federal medical procurement needs. This delivery order is classified as a child contract under AmerisourceBergen's broader federal contracting relationship and involves no set-aside...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C5JDelivery Order
The Defense Logistics Agency awarded a $1,910.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit-dose 3 mL vials. The order was competitively awarded without set-aside designation and is scheduled for completion by December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The broader IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the company to deliver a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The specific delivery order for Yupelri, a respiratory medication, exemplifies the company's role in supplying specialized pharmaceutical products to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/30/25 |